ASAS Criteria for Peripheral SpondyloArthritis (SpA)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
classification
—امتیاز
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • ——
  • ——
Direct Clinical Answer

The ASAS Criteria for Peripheral SpondyloArthritis (SpA) calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include peripheral arthritis. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Classifies peripheral spondyloarthritis according to the Assessment of SpondyloArthritis International Society (ASAS) criteria

Clinical Indication

The ASAS Criteria for Peripheral SpondyloArthritis (SpA) is indicated for bedside clinical practice to support Classifies peripheral spondyloarthritis according to the Assessment of SpondyloArthritis International Society (ASAS) criteria. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.

Limitations & Contraindications

Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.

Clinical Pearls & Action Plan

Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology.

Formula & Variables:

Entry criterion: Arthritis and/or enthesitis and/or dactylitis. Plus one or more from Group A (psoriasis, IBD, preceding infection, HLA-B27, uveitis, sacroiliitis) OR two or more from Group B (arthritis, enthesitis, dactylitis, IBP past, family history SpA)

Input Parameters

NameTypeRequiredDescription
peripheral_arthritisstringYesPeripheral arthritis (usually predominantly lower limbs and/or asymmetric arthritis)
enthesitisstringYesEnthesitis (clinically assessed)
dactylitisstringYesDactylitis (clinically assessed)
psoriasisstringYesPast or present psoriasis diagnosed by a doctor
inflammatory_bowel_diseasestringYesPast or present Crohn's disease or ulcerative colitis diagnosed by a doctor
preceding_infectionstringYesPreceding infection (urethritis/cervicitis or diarrhea within 1 month before arthritis onset)
hla_b27stringYesHLA-B27 positive testing according to standard laboratory techniques
uveitis_anteriorstringYesPast or present anterior uveitis confirmed by an ophthalmologist
sacroiliitis_imagingstringYesSacroiliitis on imaging (bilateral grade 2-4 or unilateral grade 3-4 on X-rays OR active sacroiliitis on MRI)
inflammatory_back_pain_paststringYesHistory of inflammatory back pain in the past
family_history_spastringYesFamily history of spondyloarthritis (presence in first or second-degree relatives of ankylosing spondylitis, psoriasis, uveitis, reactive arthritis, or inflammatory bowel disease)

Score Interpretation & Guidance

RangeStageDescription
——Meets ASAS criteria for peripheral spondyloarthritis
——Does not meet ASAS criteria for peripheral spondyloarthritis

Evidence-Based References (EBM)

  • Rudwaleit M, van der Heijde D, Landewé R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70(1):25-31.
  • Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68 Suppl 2:ii1-44.

Related calculators